Skip to main content
Figure 1 | Diabetology & Metabolic Syndrome

Figure 1

From: Adipocyte mitochondrial genes and the forkhead factor FOXC2 are decreased in type 2 diabetes patients and normalized in response to rosiglitazone

Figure 1

Clinical characterization and treatment effects. The clinical variables BMI (a), FMPC (b),adiponectin (c), CRP (d), glucose (e) and insulin (f) of the healthy controls and diabetic patients before and after treatment with rosiglitazone for 90 days. Bars represent mean and error bars SEM. * = p < 0.05, ** = p < 0.01, *** = p < 0.001.

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us